Skip to content
NewsBlazeIN – Lifestyle
Author:
Castle Biosciences, Inc.
Castle Biosciences’ Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal
June 23, 2026
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 19, 2026
Castle Biosciences’ TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett’s Esophagus
June 16, 2026
←
Previous Page
1
2
3